Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
13 participants
INTERVENTIONAL
2022-07-24
2022-08-24
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Does a low, moderate, or high caffeine dose improve rowing performance? How do these doses affect sleep and recovery after evening exercise? Participants completed four rowing tests after consuming either a placebo, low (3 mg/kg), moderate (6 mg/kg), or high (9 mg/kg) dose of caffeine. Researchers measured rowing time, power, heart rate, sleep quality, and daytime sleepiness.
The study found that moderate and high caffeine doses improved rowing performance the most. However, these same doses made it harder for participants to sleep well and feel alert the next day. Headaches and stomach issues were also more common with the high dose. The low dose gave smaller performance gains but caused fewer side effects.
This study shows that evening caffeine can boost performance but may hurt recovery and sleep. Athletes and coaches should weigh these trade-offs when using caffeine for late-day training or competition.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Caffeine and L-Theanine on Physical and Cognitive Performance in Trained Athletes
NCT07268573
The Effects of Acute Chicory Coffee Consumption on Exercise Performance and Metabolism
NCT07094191
How Does Altering the Timing of Pre-exercise Low-dose Caffeine Ingestion Affect Endurance Exercise Performance
NCT02985606
Efficacy of Energy Shots and Caffeine for Energy and Wakefulness Levels
NCT01755299
Timing of Meal and Caffeine Intake on Substrate Use and Exercise Efficiency
NCT04106752
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Placebo
Participants ingested an inert cellulose capsule containing no active substance approximately 60 minutes prior to performing a 2000-meter rowing ergometer time trial. This condition served as the control to compare the effects of caffeine ingestion at varying doses.
Cellulose Powder
Participants consumed an inert cellulose powder dissolved in water, containing no active caffeine. The placebo was ingested orally 60 minutes prior to the rowing performance test. This condition served as the control and was administered once per session in a randomized, double-blind, crossover design.
Low Dose Caffeine
Participants ingested a caffeine capsule at a dosage of 3 mg per kg of body mass approximately 60 minutes before the 2000-meter rowing ergometer trial. This condition was included to evaluate the ergogenic and sleep-related effects of a low evening caffeine dose.
Caffeine 3 mg/kg Oral Powder
Participants consumed caffeine in powder form at a dose of 3 milligrams per kilogram of body weight. The powder was dissolved in water and ingested orally approximately 60 minutes before the start of the 2000-meter rowing ergometer performance test. The intervention was administered once per session in a randomized, double-blind, crossover design.
Moderate Dose Caffeine
Participants ingested a caffeine capsule at a dosage of 6 mg per kg of body mass approximately 60 minutes before performing the 2000-meter rowing ergometer test. This condition represented a commonly used moderate dose to examine its impact on performance and sleep parameters.
Caffeine 6 mg/kg Oral Powder
Participants ingested caffeine in powder form, dissolved in water, at a dose of 6 milligrams per kilogram of body mass. The solution was consumed orally 60 minutes prior to the 2000-meter rowing performance test. This intervention was administered once per session as part of a randomized, double-blind, crossover design.
High Dose Caffeine
Participants ingested a caffeine capsule at a dosage of 9 mg per kg of body mass approximately 60 minutes prior to the rowing trial. This high-dose condition was used to assess the maximum ergogenic potential of caffeine and its possible detrimental effects on sleep quality and next-day recovery.
Caffeine 9 mg/kg Oral Powder
A powdered caffeine dose of 9 milligrams per kilogram was dissolved in water and consumed orally by participants 60 minutes before a 2000-meter rowing ergometer trial. The intervention was administered once per session under a randomized, double-blind, crossover design.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cellulose Powder
Participants consumed an inert cellulose powder dissolved in water, containing no active caffeine. The placebo was ingested orally 60 minutes prior to the rowing performance test. This condition served as the control and was administered once per session in a randomized, double-blind, crossover design.
Caffeine 3 mg/kg Oral Powder
Participants consumed caffeine in powder form at a dose of 3 milligrams per kilogram of body weight. The powder was dissolved in water and ingested orally approximately 60 minutes before the start of the 2000-meter rowing ergometer performance test. The intervention was administered once per session in a randomized, double-blind, crossover design.
Caffeine 6 mg/kg Oral Powder
Participants ingested caffeine in powder form, dissolved in water, at a dose of 6 milligrams per kilogram of body mass. The solution was consumed orally 60 minutes prior to the 2000-meter rowing performance test. This intervention was administered once per session as part of a randomized, double-blind, crossover design.
Caffeine 9 mg/kg Oral Powder
A powdered caffeine dose of 9 milligrams per kilogram was dissolved in water and consumed orally by participants 60 minutes before a 2000-meter rowing ergometer trial. The intervention was administered once per session under a randomized, double-blind, crossover design.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Aged approximately 22 ± 2.2 years
* Minimum of 2 years of rowing training experience
* Free of any medical condition that impairs exercise participation
* Regular caffeine consumers (habitual daily intake recorded)
* Voluntarily signed informed consent form
* Available to attend all scheduled laboratory sessions
Exclusion Criteria
* Use of prescription medications during the study period
* Known allergy to mannitol or other artificial sweeteners
* Diagnosed sleep disorders (e.g., insomnia, sleep apnea)
* Physician's advice to limit or avoid caffeine intake
20 Years
25 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ulaç Can YILDIRIM
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ulaç Can YILDIRIM
Assoc. Prof.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ulas C. Yildirim, pHd
Role: PRINCIPAL_INVESTIGATOR
Sinop University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sinop University Facility
Sinop, Centarl, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Ali A, O'Donnell JM, Starck C, Rutherfurd-Markwick KJ. The Effect of Caffeine Ingestion during Evening Exercise on Subsequent Sleep Quality in Females. Int J Sports Med. 2015 Jun;36(6):433-9. doi: 10.1055/s-0034-1398580. Epub 2015 Feb 20.
Anderson ME, Bruce CR, Fraser SF, Stepto NK, Klein R, Hopkins WG, Hawley JA. Improved 2000-meter rowing performance in competitive oarswomen after caffeine ingestion. Int J Sport Nutr Exerc Metab. 2000 Dec;10(4):464-75. doi: 10.1123/ijsnem.10.4.464.
Bonnar D, Bartel K, Kakoschke N, Lang C. Sleep Interventions Designed to Improve Athletic Performance and Recovery: A Systematic Review of Current Approaches. Sports Med. 2018 Mar;48(3):683-703. doi: 10.1007/s40279-017-0832-x.
Chen B, Ding L, Qin Q, Lei TH, Girard O, Cao Y. Effect of caffeine ingestion on time trial performance in cyclists: a systematic review and meta-analysis. J Int Soc Sports Nutr. 2024 Dec;21(1):2363789. doi: 10.1080/15502783.2024.2363789. Epub 2024 Jun 5.
de Souza JG, Del Coso J, Fonseca FS, Silva BVC, de Souza DB, da Silva Gianoni RL, Filip-Stachnik A, Serrao JC, Claudino JG. Risk or benefit? Side effects of caffeine supplementation in sport: a systematic review. Eur J Nutr. 2022 Dec;61(8):3823-3834. doi: 10.1007/s00394-022-02874-3. Epub 2022 Apr 5.
Drapeau C, Hamel-Hebert I, Robillard R, Selmaoui B, Filipini D, Carrier J. Challenging sleep in aging: the effects of 200 mg of caffeine during the evening in young and middle-aged moderate caffeine consumers. J Sleep Res. 2006 Jun;15(2):133-41. doi: 10.1111/j.1365-2869.2006.00518.x.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021/80
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.